Watch for the onset of diabetes and other cardiovascular risk factors among gout patients, particularly women. A study using US insurance claims has validated UK data that showed the same gender difference.
In court decision to approve generic colchicine for gout, American College of Rheumatology arguments about the risk to patients of exorbitant pricing may have played an important role. Is this a harbinger of something?
(VIDEO) A gout drug with a new mechanism is showing promise in combination with existing remedies. In this interview, a leader in its progress to market tells why lesinurad could help put an undertreated disorder in a new light.
(ACR2014) Our rheumatologist correspondent found three issues of particular interest: a biomarker test that has gone quickly to market, new diagnostic criteria for gout, and the potential of ultrasound for Sjögren syndrome.
(VIDEO) The fourth "Sounding Out Arthritis" video demonstrates how to use ultrasound to distinguish gout from pseudogout, with a demonstration of probe placement and narrated ultrasound images and videos.
(AUDIO) African Americans are not treated as effectively for gout as Caucasians. In this recorded interview, Dr. Jasvinder Singh ponders the meaning of this disparity and gives advice about how doctors can assure the best treatment for gout in all ethnic groups.
(AUDIO) New ACR guidelines on gout advise considering a test for the HLA-B*5801 allele linked to allopurinol sensitivity in some patients. This podcast by the co-chair of the panel clarifies the details.